Upgrade to SI Premium - Free Trial

Stoke Therapeutics (STOK) PT Raised to $60 at Canaccord

March 20, 2026 6:56 AM
(Updated - March 20, 2026 6:58 AM EDT)

Canaccord analyst Sumant Kulkami raised the price target on Stoke Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change